文献速递肺结节与肺癌

肺部筛查接受度试验(LSUT):针对性邀请材料的随机对照临床试验

Lung Screen Uptake Trial (LSUT): Randomized Controlled Clinical Trial Testing Targeted Invitation Materials.
PubMed 文献 · Am J Respir Crit Care Med · 2020-01-01

该随机对照试验在2012名60-75岁、近7年内吸烟且无LDCT禁忌的受试者中,比较针对性低负担阶梯式邀请策略与对照对医院肺部健康检查预约接受度的影响。两组接受度无差异(52.3% vs 52.9%;调整OR 0.98,95%CI 0.82-1.17),当前吸烟者接受度低于既往吸烟者(调整OR 0.70,95%CI 0.56-0.86)。

要点

  • 针对性邀请材料未提高LDCT肺癌筛查的接受度。
  • 当前吸烟者接受度显著低于既往吸烟者(调整OR 0.70)。
  • 两组共用的阶梯式邀请策略或可作为最低标准。

核心结论

  • 针对性低负担邀请材料未改善LDCT肺癌筛查的接受度。
  • 无论分组,接受度均高于既往临床和真实世界研究。

研究设计与样本

  • 两臂、盲法、组间随机对照试验,从16家初级保健机构选取2012名受试者。
  • 纳入标准:60-75岁、近7年内记录为当前吸烟者、无LDCT禁忌。
  • 两组均接受阶梯式预邀请、邀请和提醒信函,关键操纵为随附宣传册。

主要发现

  • 总体接受度为52.6%,干预组52.3%,对照组52.9%。
  • 未调整OR为0.98(95%CI 0.82-1.16),调整OR为0.98(95%CI 0.82-1.17)。
  • 当前吸烟者接受度低于既往吸烟者,调整OR为0.70(95%CI 0.56-0.86)。
  • 社会经济剥夺仅与对照组较低接受度显著相关(P < 0.01)。

临床怎么用

  • 两组共用的肺部健康检查阶梯式邀请策略可作为最低标准参考。
  • 针对当前吸烟者需额外关注以提高筛查接受度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: Low uptake of low-dose computed tomography (LDCT) lung cancer screening, particularly by current smokers of a low socioeconomic position, compromises effectiveness and equity.Objectives: To compare the effect of a targeted, low-burden, and stepped invitation strategy versus control on uptake of hospital-based Lung Health Check appointments offering LDCT screening.Methods: In a two-arm, blinded, between-subjects, randomized controlled trial, 2,012 participants were selected from 16 primary care practices using these criteria: 1) aged 60 to 75 years, 2) recorded as a current smoker within the last 7 years, and 3) no prespecified exclusion criteria contraindicating LDCT screening. Both groups received a stepped sequence of preinvitation, invitation, and reminder letters from their primary care practitioner offering prescheduled appointments. The key manipulation was the accompanying leaflet. The intervention group's leaflet targeted psychological barriers and provided low-burden information, mimicking the concept of the U.K. Ministry of Transport's annual vehicle test ("M.O.T. For Your Lungs").Measurements and Main Results: Uptake was 52.6%, with no difference between intervention (52.3%) and control (52.9%) groups in unadjusted (odds ratio [OR], 0.98; 95% confidence interval [CI], 0.82-1.16) or adjusted (OR, 0.98; 95% CI, 0.82-1.17) analyses. Current smokers were less likely to attend (adjusted OR, 0.70; 95% CI, 0.56-0.86) than former smokers. Socioeconomic deprivation was significantly associated with lower uptake for the control group only (P < 0.01).Conclusions: The intervention did not improve uptake. Regardless of trial arm, uptake was considerably higher than previous clinical and real-world studies, particularly given that the samples were predominantly lower socioeconomic position smokers. Strategies common to both groups, including a Lung Health Check approach, could represent a minimum standard.Clinical trial registered with www.clinicaltrials.gov (NCT02558101) and registered prospectively with the International Standard Registered Clinical/Social Study (N21774741).

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Quaife SL, Ruparel M, Dickson JL, et al. Lung Screen Uptake Trial (LSUT): Randomized Controlled Clinical Trial Testing Targeted Invitation Materials. Am J Respir Crit Care Med. 2020. PMID: 31825647. doi:10.1164/rccm.201905-0946OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。